Skip to content

H.R. 1672 · 119th Congress (2025–2027)

Maintaining Investments in New Innovation Act

This bill requires drug products with genetically targeted technology to have had market approval for at least 11 years in order to qualify for the Medicare Drug Price Negotiation Program. (The program requires the Centers for Medicare & Medicaid Services to negotiate the prices of certain prescription drugs under Medicare beginning in 2026. Among other requirements, drugs must have had market approval for at least 7 years (for drug products) or 11 years (for biologics) to qualify for negotiation.)

Show official title

To amend title XI of the Social Security Act to protect access to genetically targeted technologies.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 1672’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Donald G. Davis (D-NC-1)
Cosponsors
51 cosponsors

13 original · 38 later

44 R · 7 D

  1. Rep. Rick W. Allen (R-GA-12)· Original · Feb 27, 2025
  2. Rep. Aaron Bean (R-FL-4)· Original · Feb 27, 2025
  3. Rep. Dan Crenshaw (R-TX-2)· Original · Feb 27, 2025
  4. Rep. Josh Gottheimer (D-NJ-5)· Original · Feb 27, 2025
  5. Rep. Richard Hudson (R-NC-9)· Original · Feb 27, 2025
  6. Rep. John Joyce (R-PA-13)· Original · Feb 27, 2025
  7. Rep. Joseph D. Morelle (D-NY-25)· Original · Feb 27, 2025
  8. Rep. Blake D. Moore (R-UT-1)· Original · Feb 27, 2025
  9. Rep. Mariannette Miller-Meeks (R-IA-1)· Original · Feb 27, 2025
  10. Rep. Scott H. Peters (D-CA-50)· Original · Feb 27, 2025
  11. Rep. Claudia Tenney (R-NY-24)· Original · Feb 27, 2025
  12. Rep. Beth Van Duyne (R-TX-24)· Original · Feb 27, 2025
  13. Rep. Rudy Yakym III (R-IN-2)· Original · Feb 27, 2025
  14. Rep. Neal P. Dunn (R-FL-2)· Later · Mar 27, 2025
  15. Rep. Kevin Hern (R-OK-1)· Later · Apr 9, 2025
  16. Rep. Mike Carey (R-OH-15)· Later · Apr 10, 2025
  17. Rep. Jefferson Shreve (R-IN-6)· Later · May 9, 2025
  18. Rep. August Pfluger (R-TX-11)· Later · May 13, 2025
  19. Rep. Pete Sessions (R-TX-17)· Later · Jun 4, 2025
  20. Rep. Addison P. McDowell (R-NC-6)· Later · Jun 10, 2025
  21. Rep. Mike Kelly (R-PA-16)· Later · Sep 2, 2025
  22. Rep. Charles J. "Chuck" Fleischmann (R-TN-3)· Later · Sep 17, 2025
  23. Rep. Nicole Malliotakis (R-NY-11)· Later · Sep 30, 2025
  24. Rep. Daniel Meuser (R-PA-9)· Later · Sep 30, 2025
  25. Rep. Brittany Pettersen (D-CO-7)· Later · Sep 30, 2025
  26. Rep. Troy Balderson (R-OH-12)· Later · Oct 3, 2025
  27. Rep. Tim Moore (R-NC-14)· Later · Oct 17, 2025
  28. Rep. Ken Calvert (R-CA-41)· Later · Oct 31, 2025
  29. Rep. Chuck Edwards (R-NC-11)· Later · Oct 31, 2025
  30. Rep. John R. Moolenaar (R-MI-2)· Later · Oct 31, 2025
  31. Rep. Randy K. Weber, Sr. (R-TX-14)· Later · Oct 31, 2025
  32. Rep. Vince Fong (R-CA-20)· Later · Nov 4, 2025
  33. Rep. Brian Jack (R-GA-3)· Later · Nov 10, 2025
  34. Rep. Nathaniel Moran (R-TX-1)· Later · Nov 17, 2025
  35. Rep. Mike Haridopolos (R-FL-8)· Later · Nov 21, 2025
  36. Rep. Thomas H. Kean, Jr. (R-NJ-7)· Later · Nov 21, 2025
  37. Rep. Laurel M. Lee (R-FL-15)· Later · Nov 21, 2025
  38. Rep. Ashley Hinson (R-IA-2)· Later · Dec 4, 2025
  39. Rep. Kevin Mullin (D-CA-15)· Later · Dec 9, 2025
  40. Rep. Michael Lawler (R-NY-17)· Later · Jan 13, 2026
  41. Rep. Andy Barr (R-KY-6)· Later · Mar 20, 2026
  42. Rep. Gus M. Bilirakis (R-FL-12)· Later · Apr 15, 2026
  43. Rep. Nicholas A. Langworthy (R-NY-23)· Later · Jun 18, 2026
  44. Rep. Adrian Smith (R-NE-3)· Later · Jun 18, 2026
  45. Rep. Lloyd Smucker (R-PA-11)· Later · Jun 18, 2026
  46. Rep. Gabe Evans (R-CO-8)· Later · Jun 25, 2026
  47. Rep. Earl L. "Buddy" Carter (R-GA-1)· Later · Aug 10, 2026
  48. Rep. Jared Moskowitz (D-FL-23)· Later · Aug 10, 2026
  49. Rep. Brian K. Fitzpatrick (R-PA-1)· Later · Aug 27, 2026
  50. Rep. Vicente Gonzalez (D-TX-34)· Later · Sep 4, 2026
  51. Rep. Michael A. Rulli (R-OH-6)· Later · Sep 24, 2026
Policy area
Health
Subjects
  • Genetics
  • Medicare
  • Prescription drugs

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Sources

Committees

  1. HouseEnergy and CommerceReferred Feb 27, 2025
  2. HouseWays and MeansReferred Feb 27, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Maintaining Investments in New Innovation Act

    Display title, Short title · Introduced in House

  2. To amend title XI of the Social Security Act to protect access to genetically targeted technologies.

    Official title · Introduced in House